- Teva, Marksans recall popular diabetes med
Two drugmakers, Teva Pharmaceuticals and Marksans Pharma Limited, have voluntarily recalled their versions of metformin, a popular diabetes drug. - FDA asks 5 drugmakers to recall metformin products
The FDA asked five drugmakers to voluntarily recall their metformin products after it found unacceptable levels of a carcinogen in the drug. - Medtronic heart pump recalled again after link to 4 patient deaths
The FDA issued another class 1 recall of Medtronic’s HeartWare HVAD ventricular assist device after discovering a design issue that has caused four patient deaths. - Apotex recalls diabetes drug after FDA alert
Apotex, a drugmaker based in Toronto, is recalling all lots of its metformin extended-release tablets after the FDA said it found unacceptable levels of a carcinogen in the drug. - Medtronic recalls brain surgery device
Medtronic recalled its StealthStation software, which provides images of a patient’s brain to help surgeons navigate surgical tools and implants used during brain surgery, due to inaccuracies caused by minor patient movements which could cause serious or life-threatening patient harm. - Georgia pharma company recalls thyroid drug for super-potency
Alpharetta, Ga.-based Acella Pharmaceuticals recalled 13 lots of NP Thyroid after finding the drug to be super-potent.
More articles on pharmacy:
States sue 26 generic drugmakers, accused of fixing prices since 2016
Virginia pharmacist pleads guilty to federal drug fraud
NIH to fund, conduct 3 end-stage COVID-19 vaccine trials this summer
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.